KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED
Get an alert when KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-14 (in 8mo)
Last made up 2025-12-31
Watchouts
None on the register
Cash
£10K
-16.7% vs 2023
Net assets
£3M
+2% vs 2023
Employees
13
-13.3% vs 2023
Profit before tax
£1M
-14.5% vs 2023
Name history
Renamed 1 time since incorporation
- KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED 2016-04-18 → present
- STRAKAN PHARMACEUTICALS LIMITED 1996-12-31 → 2016-04-18
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £7,045,000 | £5,527,000 | |
| Operating profit | £1,729,000 | £1,005,000 | |
| Profit before tax | £1,570,000 | £1,342,000 | |
| Net profit | £1,539,000 | £1,063,000 | |
| Cash | £12,000 | £10,000 | |
| Total assets less current liabilities | £3,096,000 | £3,152,000 | |
| Net assets | £3,089,000 | £3,152,000 | |
| Equity | £3,089,000 | £3,152,000 | |
| Average employees | 15 | 13 | |
| Wages | £2,017,000 | £1,562,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 24.5% | 18.2% | |
| Net margin | 21.8% | 19.2% | |
| Return on capital employed | 55.8% | 31.9% | |
| Current ratio | 1.10x | 1.11x | |
| Interest cover | 1.29x | 0.89x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis which the directors believe to be appropriate.”
Significant events
- “On 24th November 2022, the KKI Group, of which Kyowa Kirin Pharmaceutical Development Limited is a 100% subsidiary company of, announced a joint venture collaboration (JVC) with Grünenthal GmbH for the established medicines portfolio. The JVC includes a portfolio of brands across six therapeutic areas, with revenues primarily resulting from pain management medicines. The deal completed on 1 August 2023. KKI Group has created new legal entities as a vehicle for the JVC, including a holding company for the joint venture. Grünenthal own a 51 percent majority share in the newly formed JVC. On 1 August 2023, the established medicine portfolio along with certain assets transferred to the joint venture vehicle. The Company hence no longer provides services to the established medicines business.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MCS FORMATIONS LIMITED | Corporate Secretary | 2013-10-17 | — | — |
| ARISTIDOU, Antrinkos Andrew | Director | 2020-09-28 | Jun 1968 | British |
| REISINGER, Roswitha, Dr | Director | 2020-04-22 | May 1970 | Austrian |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BYRNE, Patricia Mary | Secretary | 1997-03-25 | 2004-03-31 |
| GODFREY, Susan Anne | Secretary | 1996-12-31 | 2012-03-15 |
| VALE, Iryna | Secretary | 2012-06-27 | 2013-10-17 |
| CLARKE, Janet | Director | 1997-03-25 | 2010-07-18 |
| COLLINS, Clive John | Director | 1997-12-02 | 2002-08-06 |
| FLETCHER, John | Director | 1998-03-27 | 2000-09-30 |
| GARDNER, Adrian David Edmund | Director | 2004-07-08 | 2007-06-29 |
| GARVEY, Paul Maurice | Director | 2007-04-16 | 2009-08-11 |
| GRAY, Derek Richard | Director | 1996-12-31 | 2004-09-15 |
| KING, Alan Fernie | Director | 2020-04-22 | 2023-08-01 |
| LAWRENCE, David Muir | Director | 2001-04-06 | 2001-10-24 |
| MCLEAN, Andrew Firth | Director | 2007-04-17 | 2020-04-22 |
| MCLEAN, Andrew Firth | Director | 1997-12-02 | 2003-02-28 |
| MORGAN, Jeremy Lewis | Director | 2023-02-22 | 2025-11-03 |
| REYNOLDS, Graham Keith Austen | Director | 1999-12-20 | 2000-01-30 |
| SCALES, Michael David Courtney, Dr | Director | 2001-02-01 | 2001-10-31 |
| STRATFORD, Caroline Anne | Director | 1997-07-04 | 2000-05-25 |
| STRATFORD, Harry Thomas, Dr | Director | 2008-12-31 | 2019-03-31 |
| STRATFORD, Harry Thomas, Dr | Director | 2000-05-25 | 2008-06-30 |
| STRATFORD, Harry Thomas | Director | 1997-07-04 | 2008-07-07 |
| TOTTEN, Joseph Wilson | Director | 2009-09-09 | 2010-09-06 |
| VICKERS, Jane Ann | Director | 1998-09-28 | 2005-12-15 |
| VICKERS, Jane Ann | Director | 1997-03-25 | 1998-03-27 |
| WATSON, Allan Mark | Director | 2009-09-09 | 2020-04-22 |
| WATSON, Evelyn Isobel | Director | 2010-03-09 | 2016-05-09 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Kyowa Kirin International Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-19 | Active |
| Kyowa Kirin Services Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-01-01 | Ceased 2019-12-19 |
| Kyowa Kirin International Plc | Corporate entity | Shares 50–75% | 2016-04-06 | Ceased 2018-01-01 |
Filing timeline
Last 20 of 159 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2025-08-22 | CH01 | officers | Change person director company with change date | |
| 2025-01-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-01-11 | AA | accounts | Accounts with accounts type full | |
| 2024-01-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-07 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-05 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-02 | CH01 | officers | Change person director company with change date | |
| 2023-02-02 | CH01 | officers | Change person director company with change date | |
| 2023-02-01 | CH01 | officers | Change person director company with change date | |
| 2023-02-01 | CH01 | officers | Change person director company with change date | |
| 2023-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-05 | AA | accounts | Accounts with accounts type full | |
| 2022-01-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-05 | CH01 | officers | Change person director company with change date | |
| 2021-09-13 | CH01 | officers | Change person director company with change date | |
| 2021-09-11 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-21.5%
£7,045,000 £5,527,000
-
Cash
-16.7%
£12,000 £10,000
-
Net assets
+2%
£3,089,000 £3,152,000
-
Employees
-13.3%
15 13
-
Operating profit
-41.9%
£1,729,000 £1,005,000
-
Profit before tax
-14.5%
£1,570,000 £1,342,000
-
Wages
-22.6%
£2,017,000 £1,562,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers